Other Open Access
Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine CIN/Wart Efficacy Study (Study 013) - March 2003 / Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine, Safety, Immunogeneicity and Efficacy Study (Study 015) FUTURE II - July 2003
Lupinacci, Lisa; Railkhar, Radha
2003_FDA_r_s_DAP-Gardasil-HPV-013.pdf
Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine CIN/Wart Efficacy Study (Study 013) March 2003
2003_FDA_r_s_DAP-Gardasil-HPV-015.pdf
Statistical Data Analysis Plan HPV Quadrivalent HPV Vaccine, Safety, Immunogenicity and Efficacy Study (Study 015) FUTURE II - July 2003
We obtained Gardasil® Data Analysis Plans (DAPs) from the FDA through Freedom of Information Act (FOIA) request. The above linked DAPs specified a “per protocol analysis” for the outcome CIN 2+ irrespective of HPV type.
Files
(6.2 MB)
| Name | Size | |
|---|---|---|
|
2003_FDA_r_s_DAP-Gardasil-HPV-013.pdf
md5:05c48505dce234778e2c5aa9f1e8b3e0 |
2.7 MB | Download |
|
2003_FDA_r_s_DAP-Gardasil-HPV-015.pdf
md5:c9500e80ede7382540f187fc65f24ad9 |
3.5 MB | Download |
232
108
views
downloads
| All versions | This version | |
|---|---|---|
| Views | 232 | 232 |
| Downloads | 108 | 108 |
| Data volume | 307.0 MB | 307.0 MB |
| Unique views | 219 | 219 |
| Unique downloads | 75 | 75 |
Indexed in
- Publication date:
- March 4, 2003
- DOI:
-
- Keyword(s):
- HPV vaccine Gardasil Approval Data Analysis Plan
- License (for files):
- Creative Commons Attribution 4.0 International